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Chemicals  can  interact  with  the  genetic  material  giving  rise  to  the  formation  of  covalent  adducts.  These
alterations  can  lead to adverse  consequences,  including  cancer,  reproductive  impairment,  development
anomalies,  or  genetic  diseases.  In search  for  an  assay  allowing  identiﬁcation  of hazardous  compounds  that
might  form  covalent  adducts  with  nucleic  acids,  electrochemistry  (EC)/liquid  chromatography  (LC)/mass
spectrometry  (MS)  is  presented.  EC/LC/MS  is  a  purely  instrumental  approach.  EC is  used  for  oxidative
activation,  LC for  the  fractionation  of  the  reaction  mixture,  and  MS for the  detection  and  characterization
of  the reaction  products.  To  test  the  system  capabilities,  we investigated  the  formation  of  covalent  adducts
produced  by  guanosine  and  acetaminophen  (APAP).  Electrochemical  activation  of mixtures  of guanosineiquid chromatography
NA adduct
NA damage
and APAP  gave  rise  to the formation  of  four  isomers  of  (guanosine  + APAP-2H).  Mass  voltammograms
as  well  as  dose–response-curves  were  used  to obtain  insights  in  the  mechanism  of adduct  formation.
These  experiments  revealed  that a  mechanism  involving  radical  intermediates  is favored.  The  initial step
of adduct  formation  is  the  conversion  of  both  APAP  and  guanosine  into  radicals  via one-electron–one-
proton  reactions.  Among  different  competing  reaction  pathways,  the  generated  radical  intermediates
undergo  intermolecular  reactions  to  form  covalent  adducts  between  guanosine  and  APAP.. Introduction
Humans are constantly being exposed to increasing num-
ers of mutagenic, genotoxic or carcinogenic chemicals in their
veryday lives. These chemicals such as or activated via oxida-
ive processes can react with nucleic acids giving rise to the
ormation of monoadducts, intrastrand cross-links, interstrand
ross-links, and/or interhelical cross-links. These modiﬁcations can
lter sequence, structure, function or segregation of the genetic
aterial, and may  lead to adverse consequences, including can-
er, reproductive impairment, development anomalies, or genetic
iseases.
A number of assays have been developed to identify poten-
ially hazardous chemicals. The standard regulatory test battery
enerally includes an assessment of genotoxicity in bacterial and
ammalian cells in vitro together with rodent assays for chro-
osomal and/or DNA damage [1,2]. Despite considerable success
f these assays, there is still a need for tests that are quicker,
ore easily automatable, and less expensive than the existing
 This paper is part of the special issue “LC–MS/MS in Clinical Chemistry”, Edited
y  Michael Vogeser and Christoph Seger.
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assays. A particular demand for novel technologies allowing reac-
tivity assessment of chemicals exists in drug development or large
scale chemical evaluation programs such as European REACH (The
Registration, Evaluation, Authorisation and Restriction of Chemi-
cal substances) legislation. In a workshop recently organized by
the “In Vitro Genetic Toxicity Testing Project Committee” sixteen
assays/technologies were reviewed which either could replace or
complement the existing standard test battery [3].  One of the meth-
ods discussed was DNA adduct screening by liquid chromatography
(LC)/mass spectrometry (MS) [4].
LC/MS is a commonly used method for the characterization of
modiﬁed nucleic acids species including DNA adducts [5–13]. LC
enables the separation of modiﬁed and unmodiﬁed species and
is particularly helpful in the detection of isomers. MS  provides
sufﬁcient sensitivity and speciﬁcity and the ability to elucidate
modiﬁed DNA structures. With LC/MS adducts are usually detected
at the nucleobase, nucleoside, or nucleotide level after enzymatic
digestion (typically DNase I or nuclease P1). A critical part of the
developed workﬂows is activation of the adduct-forming agents. In
most cases bioactivation includes oxidation by cytochrome P450
(CYP) enzymes. Induced rodent liver S9 represents the exoge-
Open access under CC BY-NC-ND license.nous activation system of choice. Alternatively, the use of human
liver S9, genetically modiﬁed bacteria and mammalian cells, as
well as recombinant human CYPs has been proposed. Reported
problems of available bioactivation assays include: (i) due to the
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ubstrate-speciﬁcity of enzymes a large variety of oxidizing
nzymes is needed for exhaustive activation; (ii) cofactors are nec-
ssary for efﬁcient transformation reactions; (iii) organic solvents
ecessary to dissolve lipophilic molecules can decrease enzyme
ctivity; (iv) highly concentrated test compound solutions induce
ubstrate saturation or enzyme inhibition; (v) active metabolites
an react with a number of alternative targets (e.g. proteins, lipids).
n search of an alternative activation system the use of electro-
hemistry (EC) was proposed [14–16].  EC represents a versatile
ool to mimic  metabolic oxidation reactions [17,18]. EC provides
 means to generate reactive metabolites without the need of any
ind of chemical or biological oxidizer in an environment where
nly selected biological nucleophiles (i.e. proteins, peptides, small
olecules) are present [19–21].
In this work an integrated EC-LC–MS system for studying adduct
ormation processes is presented. EC/LC/MS is a purely instrumen-
al approach that is capable to automatically produce, detect and
haracterize covalent DNA adducts. To test the system capabili-
ies, we investigated the formation of covalent adducts produced
y guanosine and acetaminophen (APAP). Mechanistic details of
he electrochemical adduct formation process are discussed.
. Materials and methods
.1. Chemicals
Acetonitrile, guanosine, APAP (acetaminophen, paracetamol, N-
cetyl-p-aminophenol, CAS no. 103-90-2) and water were obtained
rom Sigma–Aldrich (St. Louis, MO,  USA). Ammonium hydroxide
nd formic acid were purchased from Fluka (Buchs, Switzerland).
ll chemicals were used in the highest quality available.
.2. The EC-LC–MS system
All experiments were performed on a modiﬁed ROXY EC/LC
ystem (Antec, Zoeterwoude, The Netherlands) online hyphenated
o a quadrupole–quadrupole-time-of-ﬂight mass spectrometer
QqTOF; QSTAR XL, AB Sciex, Foster City, CA, USA). A schematic
rawing of the setup is provided in Fig. 1.
Electrochemical conversions were accomplished in an elec-
rochemical thin layer cell (ReactorCell, Antec). The reactor cell
onsisted of a three electrode arrangement including a working
lectrode, a counter electrode and a reference electrode. As work-
ng electrode a conductive diamond electrode (Magic Diamond,
ntec) was used. Conductive diamond is an ideal electrode mate-
ial for the oxidation of nucleic acids due to its chemical inertness,
igh electrical conductivity, and extraordinarily low catalytic activ-
ty for both, hydrogen and oxygen evolution. The effective area of
he working electrode was 15.1 mm2. The inlet block of the cell
as employed as counter electrode and a Pd/H2 electrode (HyREF,
ntec) was used as reference electrode. The working electrode and
he counter electrode inlet block were separated by a 50 m spacer
iving a cell volume of approx. 750 nl. Electrochemical potentials (E,
–4000 mV)  were applied using a potentiostat (ROXY Potentiostat,
ntec).
For automated sample delivery, the reactor cell was integrated
nto the autosampler system [22]. The reactor cell was  placed
etween the injection capillary and the injection valve. Sample
olutions containing 300–350 M guanosine and 0–350 M APAP
issolved in 10 mM ammonium formate (pH 7.3) were delivered
hrough the electrochemical cell at a ﬂow rate of 2.5 L/min to the L sample loop.
For all experiments a miniaturized chromatographic system
as used. Chromatographic separations were accomplished on
 micro-column (200 mm × 0.2 mm i.d., Eurospher C18, 5 m) 883– 884 (2012) 198– 204 199
prepared according to the published protocol [23–25].  A primary
ﬂow of 250 L/min was split by a ratio of 1:100 to a ﬁnal ﬂow of
2.5 L/min with the help of a tee-piece and a 50 m i.d. fused-silica
restriction capillary. The connection line between the gradient
mixer and the splitting tee-piece was made of a 100 m i.d. Peek
tubing; all other transfer lines had an i.d. of 20 m to mini-
mize extra-column peak broadening. Chromatographic separations
were accomplished with linear gradients of 2.5–30% acetonitrile
in 10 mM ammonium formate (pH 7.3) within 10 min. The EC/LC
system was  controlled by the Clarity Chromatography software
(DataApex, Prague, Czech Republic).
Eluting compounds were detected by electrospray ionization
(ESI)-MS in positive ion mode, which was  performed on a QSTAR XL
mass spectrometer (AB Sciex) equipped with a modiﬁed TurboIon-
Spray source [26,27].  The modiﬁcations included the replacements
of the Peek tubing transfer line and of the stainless steel sprayer
capillary by fused silica capillaries (transfer line: 375 m o.d.,
20 m i.d., sprayer capillary: 90 m o.d., 20 m i.d., Polymicro
Technologies Phoenix, AZ, USA). Mass spectrometric parameters
were optimized using a 100 M solution of guanosine in 10 mM
ammonium formate (pH 7.3) containing 50% acetonitrile (v/v).
The spray voltage was  set to 4.5 kV. Gas ﬂows of 2–5 arbitrary
units (nebulizer gas) and 25–30 arbitrary units (turbo gas) were
employed. The temperature of the turbo gas was adjusted to 200 ◦C.
For MS/MS, the resolution of the ﬁrst quadrupole was  set to unit res-
olution. The collision gas (N2) ﬂow was  set to 5 arbitrary units, and
a collision energy of 15 eV was  applied. For MS3, up front fragmen-
tation, which was  induced by increasing the declustering potential
from 55 V to 135 V, was  combined with MS/MS  at a collision energy
of 30 eV. Accumulation time was set to 0.5 s, and a scan range
50–700 was  used. Mass spectra were recorded on a personal com-
puter with the Analyst QS software (version 1.0, service pack 8, AB
Sciex).
3. Results and discussion
3.1. EC/LC/MS/MS of APAP-guanosine mixtures
As reported recently, on-line EC/MS can be used to study cova-
lent adduct formation of nucleic acids with different reactants,
such as small molecules [15], amino acids and peptides [16]. For
such experiments, guanine-containing species represent the test
compounds of choice since guanine has the lowest oxidation poten-
tial of all four DNA nucleobases. In both studies adducts of the
form (guanine + reactant-2H) were observed. In one study (gua-
nine + reactant)-species were detected as well [16]. These putative
covalent adducts turned out to have the same molecular formula as
the corresponding noncovalent adducts. As the proton-bound com-
plexes are known to survive the ESI process, non-covalent forms
can easily be misinterpreted as covalently bound species in MS.  To
enable the differentiation of covalent and noncovalent adducts, the
hyphenation of LC and tandem mass spectrometry (MS/MS) was
used for screening the reaction mixture. LC is intended to denature
proton-bound adducts, and MS/MS  allows structural characteriza-
tion of any kind of adduct formed.
To test the capabilities of EC/LC/MS in studying adduct forma-
tion processes, mixtures of guanosine and APAP were selected as
samples. APAP is a widely used over-the-counter analgesic and
antipyretic, and is therefore a major ingredient in numerous cold
and ﬂu remedies. Several studies on cell cultures and rodents have
demonstrated that acetaminophen can covalently bind to nucleic
acids after metabolic activation [28]. Moreover, electrochemical
oxidation of APAP is well understood [29], and was  used to initiate
adduct formation with nucleic acid species [15].
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Mig. 1. Schematic drawing of the EC-LC-MS system. (1) Solvent reservoirs, (2a, 2b) h
radient mixer, (6) splitting tee-piece and restriction capillary, (7) autosampler, (8) 
SI  source, (14) mass spectrometer.
Mixtures of guanosine and APAP were electrochemi-
ally activated and screened for adducts with LC/MS/MS.
hromatographic separations were accomplished on a minia-
urized reversed-phase column. Beneﬁts of using such a setup
nclude increased mass sensitivity with concentration-sensitive
etectors and easier coupling with MS.  Speciﬁc and sensi-
ive detection of adducts was accomplished by MS/MS. Both
dduct forms, (guanosine + APAP) and (guanosine + APAP-2H),
ere targeted. No evidence for the formation of (guano-
ine + APAP) was  found; only (guanosine + APAP-2H)-adducts were
etected.
An extracted ion chromatogram obtained for adducts of the
orm (guanine + reactant-2H) is shown in Fig. 2. Due to chromato-
raphic separation, ﬁve putative adducts were detected. Retention
imes (tr) were between 9.3 and 11.7 min. Mass spectrometric
ig. 2. Extracted ion chromatogram to identify putative (guanosine + APAP-2H)-adducts
A)  10 mM ammonium formate, pH 7.3, (B) 10 mM ammonium formate containing 50% a
S/MS,  precursor ion 433.1, scan 50–700; sample, 350 M guanosine and 200 M APAP ressure gradient pumps, (3) degasser unit, (4a, 4b) pressure pulsation dampers, (5)
ion valve, (9) needle, (10) EC ﬂow cell, (11) potentiostat, (12) capillary column, (13)
measurements were accomplished on a QqTOF instrument allow-
ing accurate measurements of mass-to-charge ratios (m/z) in MS
and MS/MS  mode. The obtained mass spectrometric information
was  used to characterize the molecular structures of the adducts.
For all ﬁve species, neutral loss of the ribose moiety was observed
(433.1 > 301.1), which is a clear indicator that on the one hand
guanosine is part of the molecule and that on the other hand
the modiﬁcation involved only the nucleobase and not the sugar.
For four species detected, the measured m/z-values were within
±30 ppm of the calculated values proving the formation of (guano-
sine + APAP-2H). For one species (“unknown adduct”, tr = 10.8 min)
the m/z value of the precursor ion as well as the m/z of the
most intense fragment ion showed mass deviations of −107 and
−66 ppm, respectively. This observation suggests that here an
unknown compound, putatively some kind of impurity within the
. E, 1750 mV;  column, Eurospher C18, 5 m, 200 mm × 0.2 mm i.d.; mobile phase
cetonitrile (v/v), pH 7.3; linear gradient, 5–60% B in 10 min; ﬂow rate, 2.5 L/min;
dissolved in 10 mM ammonium formate, pH 7.3.
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Fig. 3. Dose–response-curves for different guanosine adducts. Sample, 350 M
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ll  other conditions as in Fig. 2.
eaction mixture, might have formed a covalent adduct with guano-
ine.
.2. Dose–response-curves
As a further proof of adduct formation between guano-
ine and APAP, the amount of APAP added to the reaction
ixture was varied. The remaining experimental parameters,
ncluding guanosine concentration (350 M)  and the electro-
hemical potential (1750 mV), were kept constant. Samples were
creened with LC/MS/MS after electrochemical activation. The
btained “dose–response-curves” are depicted in Fig. 3. The four
guanosine + APAP-2H) isomers were only observed in solutions
ontaining APAP. For the isomers 1–3 the normalized peak areas
howed a steady increase over the concentration range studied
Fig. 3a). For isomer 4 maximum peak area was reached at 100 M
PAP; at higher concentration a decline of the peak area was
bserved (Fig. 3a). The unknown adduct eluting at 10.8 min  was
ormed without the addition of APAP to the reaction mixture
Fig. 3b). The peak area remained almost constant over the concen-
ration range studied. The relative standard deviation was  13.0% for
he peak area. These two observations were taken as indication that
he adduct-forming agent was an impurity part of the guanosine
ample.Fig. 4. Mass voltammograms for oxidation products of APAP, guanosine as well as
the (guanosine + APAP-2H)-adducts. E, 0–4000 mV. All other conditions as in Fig. 2.
3.3. Mechanistic details of electrochemically activated adduct
formation
In a further set of experiments mass voltammograms were
acquired to study mechanistic details of (guanosine + APAP-2H) for-
mation by electrochemical activation (Fig. 4). Solutions of 350 M
guanosine and 200 M APAP in 10 mM ammonium formate (pH
7.3) were used as samples. The potential was ramped from 0 mV  to
4000 mV. Screening for oxidation products was  accomplished by
LC/MS/MS. Targeted species included (APAP-H)2, (guanosine-H)2,
8-hydroxyguanosine as well as the adducts.
The results obtained for (APAP-H)2 are depicted in Fig. 4a.
(APAP-H)2 was  included in the study because it can be used as
indicator for oxidative activation of APAP. Due to the use of LC,
two  isomeric forms of the APAP dimer were discernible, eluting at
11.8 min  and 14.6 min, respectively. The minimum potential neces-
sary to induce APAP oxidation was  750 mV.  Maximum peak areas
were reached at 1000 mV.  At higher potentials peak areas were
declining.
Mass voltammograms of guanosine oxidation products are
summarized in Fig. 4b. Guanosine oxidation started at 1250 mV.
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Table 1
Comparison of neutral losses characteristic for guanine, APAP as well as fragments obtained from up front fragmentation of the four (guanosine + APAP-2H) isomers.
Guanine [Guanosine + APAP-2H] isomer APAP
1 2 3 4
Precursor ion for MS/MS  152.06 301.10 301.10 301.10 301.10 152.07
Characteristic neutral losses
−17.02 x x x
x x x x −18.01
−24.01
−42.02  x x x x −42.01
−59.05  x x x x −59.04
−70.02
x  x x −87.03
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he primary oxidation product was (guanosine-H)2. LC separation
nabled the detection of two isomeric forms eluting at 9.0 min
nd 11.5 min. Maximum peak areas were reached at 1750 mV  and
500 mV,  respectively. The minimum voltage necessary to detect
-hydroxyguanosine was 1500 mV;  the maximum peak area was
eached at 3500 mV.
Mass voltammograms of all ﬁve guanosine adducts detected are
hown in Fig. 4c. Adduct formation started at 1250 mV.  Maximum
eak areas were obtained at 1750 mV.  At higher voltages declining
eak areas were observed. The mass voltammograms of the adducts
ere congruent with the mass voltammogram of the (guanosine-
)2 isomer eluting at 9.0 min.
APAP has a lower oxidation potential than guanosine. APAP oxi-
ation started at 750 mV.  A minimum potential of 1250 mV  was
ecessary to initiate guanosine oxidation. For both compounds,
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(c) isomer 3
301.06
301.10
242.06
284.07
283.04
242.06
214.07
214.07
259.10
259.08
177.07
187.06
283.04
ig. 5. MS3 spectra of (guanosine + APAP-2H)-adducts. Up front fragmentation inducing
ample, 300 M guanosine and 300 M APAP dissolved in 10 mM ammonium formate, pinitial oxidation occurred in a one-electron–one-proton step to give
a free radical moiety. Due to their short lifetimes, the radicals were
not detected with our setup; they were detected indirectly. The
observed formation of the dimeric forms represented clear hints
for the production of the radical intermediates. The dimers resulted
from recombination of two radicals. As the radicals had tautomeric
structures, several combinations were possible to give different
isomeric forms.
A reaction mechanism similar to the formation of (guanosine-
H)2 and (APAP-H)2 is proposed for adduct formation. The initial
step of adduct formation is the conversion of both APAP and guano-
sine into the radical forms via one-electron–one-proton reactions.
These radicals can react with each other to form (guanosine + APAP-
2H). This hypothesis is supported by the fact that adducts were only
detected at potentials sufﬁciently high to oxidize both compounds.
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(b) isomer 2
(d) isomer 4
301.10
301.09
284.06
283.04
214.07
242.07
259.10
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283.04
259.10
242.07200.07
187.07
160.05
 cleavage of the ribose was combined with MS/MS. MS/MS, precursor ion 301.1;
H 7.3. All other conditions as in Fig. 2.
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xtensive APAP oxidation alone did not give rise to adduct forma-
ion. Simultaneous activation of guanosine was necessary to obtain
etectable amounts of covalent adducts. Tautomerization of the
adicals led to the formation of isomeric forms.
The mass voltammogram of the unknown adduct and of the
someric forms (guanosine + APAP-2H) were congruent. This obser-
ation suggests that the proposed reaction mechanism for the
ormation of adducts via electrochemical coactivation might be
ransferable from APAP to other chemicals.
.4. Insights into the structures of the (guanosine + APAP-2H)
somers from MS3 experiments
LC–MS/MS is a sensitive tool to detect modiﬁed guanosine
pecies. Four different isomers of (guanosine + APAP-2H) were
dentiﬁed by scanning the neutral loss of the ribose moiety
433.1 > 301.1). Such scanning experiments, however, do not pro-
ide any information on the structure of the modiﬁed nucleobases.
o overcome this limitation, full scan MS/MS  spectra were acquired
nd interpreted. The spectra obtained from the (guanosine + APAP-
H) isomers are depicted in Fig. 2. In all cases the number of
pectral features observed was low; neutral loss of the ribose moi-
ty was the most dominant fragmentation reaction. Only for the
rst two isomers abundant fragments characteristic for cleavage
ithin the modiﬁed nucleobases (242.1) were observed within
he MS/MS  spectra. To get more detailed structural informa-
ion, MS3 experiments were conducted. To convert the QqTOF
nstrument into a MS3 instrument up front fragmentation was
ombined with MS/MS  [30]. Up front fragmentation was used
o initiate loss of the ribose moiety (433.1 > 301.1). The obtained
ragment ions, which represented protonated (guanine + APAP-2H)
ons, were selected as precursor ions for consecutive MS/MS exper-
ments. MS3 spectra obtained from the four isomeric forms are
epicted in Fig. 5. In each spectrum a number of neutral losses
ere detected that were related to guanine and/or APAP frag-
entation (Table 1). The obtained data was particularly useful
o elucidate the site of modiﬁcation within the APAP moiety.
PAP-speciﬁc fragmentation included loss of water (−18.01), par-
ial or complete loss of the acetamido group (−42.01, −59.04) as
ell as combinations thereof (−87.03), and suggested that guano-
ine was directly linked to the aromatic ring of APAP. To localize
r at least to limit the number of possible reactive sites within
he guanosine moieties, an equivalent amount of spectral fea-
ures was missing. The cleavage of NH3 (−17.02) was the only
uanosine-speciﬁc loss observed. Nevertheless, based on the occur-
ence of this fragment ion linkage of APAP to the exocyclic N2 was
xcluded.
EC/LC/MS represents a convenient tool for the identiﬁcation
f compounds reacting with nucleic acids species after electro-
hemical activation. EC/LC/MS can be regarded as fast, simple and
utomatable screening tool. The provided amount of structural
nformation is usually sufﬁcient to narrow down the number of
ossible reaction sites by excluding moieties from being mod-
ﬁed. With mass spectrometric methods, however, only in rare
ases unequivocal localization of the linkage sites is possible.
ore detailed structural information can be obtained from other
ypes of spectroscopic methods [19]. Nuclear magnetic resonance
NMR) spectroscopy, for instance, clearly surpasses MS  in terms
f obtainable structural information. Due to its limited detection
ensitivity, however, NMR  can hardly be used as online detec-
ion method for EC/LC. The quantities needed for NMR  even
ith most modern instrumentation are at least three orders of
agnitude higher than those produced by EC, which renders
C/LC/NMR inappropriate for the development of any kind of
creening tool.
[
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4. Conclusions
EC/LC/MS represents an integrated system solution capable to
simultaneously produce, resolve and characterize covalent adducts
of small molecules with nucleic acids. In comparison to other
in vitro assays developed to identify potentially hazardous chemi-
cals EC/LC/MS is a purely instrumental assay; problems related to
biological processes (i.e. activation, transport, side reactions) are
not encountered. Oxidation reactions take place in a controlled
environment. All kind of oxidizing enzymes or chemicals are sub-
stituted by an electrode with controlled electrochemical potential.
LC/MS is used to characterize the reaction mixture leaving the elec-
trochemical reactor cell. Chromatographic separation reduces the
complexity of the sample introduced into the mass spectrometer.
LC contributes to the sensitivity of the whole method as ion sup-
pression effects are reduced and as analytes are concentrated on
the column to chromatographic peaks before entering MS.  Further-
more, isomeric species become discernible. Structural information
can be obtained from MS  and MS/MS  experiments.
EC/LC/MS is particularly useful to study experimental and mech-
anistic details of the adduct formation process. The effect of
reactant concentration on adduct formation can be deduced from
dose–response-curves. Insights into the mechanism of adduct for-
mation can be obtained from mass voltammograms. We  found
that electrochemically activated mixtures of APAP and guanosine
seem to favor a mechanism involving radical intermediates. Both
APAP and guanosine are converted into radical forms via one-
electron–one-proton reactions. These radicals can react with each
other to form (guanosine + APAP-2H). Further experiments are nec-
essary to decide whether the radical mechanism is limited to APAP
or common to other adduct-forming species as well. For validation
of the assay, the transferability of the results from electrochemi-
cal oxidation to in vitro and also in vivo systems will have to be
shown since the generally accepted mechanism of adduct forma-
tion includes activation of the adduct-forming agent to a reactive
electrophile that can bind to nucleophilic sites of nucleic acids.
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